Cargando…
Welcome back Kotter–Developing a National Allergy strategy for Australia
BACKGROUND: Allergic diseases have become an increasing health issue worldwide, being one of the fastest growing chronic diseases in Australia and other westernized countries. In 2013, allergic diseases were reported to affect 20% of the Australian population. Despite the high prevalence there was n...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574709/ https://www.ncbi.nlm.nih.gov/pubmed/36267355 http://dx.doi.org/10.1016/j.waojou.2022.100706 |
_version_ | 1784811160662441984 |
---|---|
author | Vale, Sandra L. Said, Maria Smith, Jill Joshi, Preeti Loh, Richard KS. |
author_facet | Vale, Sandra L. Said, Maria Smith, Jill Joshi, Preeti Loh, Richard KS. |
author_sort | Vale, Sandra L. |
collection | PubMed |
description | BACKGROUND: Allergic diseases have become an increasing health issue worldwide, being one of the fastest growing chronic diseases in Australia and other westernized countries. In 2013, allergic diseases were reported to affect 20% of the Australian population. Despite the high prevalence there was no national strategy to address these complex health issues, to enable the health system to manage the increasing number of patients. This project aimed to develop and implement a national strategy to improve allergy management in Australia, with a view of improving the quality of life of people living with or caring for someone with allergic diseases. METHODS: The need for a national strategy to improve allergy management was identified. The Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA) worked together as partners to progress a national strategy using a theoretical model to underpin its development. Unrestricted education grants were sought to fund engagement with stakeholder organizations for both development and implementation summits. Several stages of advocacy were undertaken. RESULTS: The National Allergy Strategy was developed as a partnership between ASCIA and A&AA. The Kotter's Change Management Model provided the basis for the steps undertaken to develop and implement the National Allergy Strategy. Two Allergy Summits, one for development and the other for implementation, were held. Several events were held to advocate for federal government funding. Five individual funding grants were achieved to implement National Allergy Strategy projects addressing the most urgent issues. CONCLUSION: The development of the National Allergy Strategy, a partnership between ASCIA and A&AA, was important in enabling successful advocacy for funding and implementation of important Australia-wide projects. The partnership has also helped facilitate engagement with key stakeholders to help advocate for funding and provide guidance and expertise in project implementation and resource development. The National Allergy Strategy has been successful in attracting funding to implement projects and develop resources urgently needed. The National Allergy Strategy has also provided a framework and a collaborative approach, for advocacy for further funding and future work to be undertaken. |
format | Online Article Text |
id | pubmed-9574709 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | World Allergy Organization |
record_format | MEDLINE/PubMed |
spelling | pubmed-95747092022-10-19 Welcome back Kotter–Developing a National Allergy strategy for Australia Vale, Sandra L. Said, Maria Smith, Jill Joshi, Preeti Loh, Richard KS. World Allergy Organ J Full-Length Article BACKGROUND: Allergic diseases have become an increasing health issue worldwide, being one of the fastest growing chronic diseases in Australia and other westernized countries. In 2013, allergic diseases were reported to affect 20% of the Australian population. Despite the high prevalence there was no national strategy to address these complex health issues, to enable the health system to manage the increasing number of patients. This project aimed to develop and implement a national strategy to improve allergy management in Australia, with a view of improving the quality of life of people living with or caring for someone with allergic diseases. METHODS: The need for a national strategy to improve allergy management was identified. The Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA) worked together as partners to progress a national strategy using a theoretical model to underpin its development. Unrestricted education grants were sought to fund engagement with stakeholder organizations for both development and implementation summits. Several stages of advocacy were undertaken. RESULTS: The National Allergy Strategy was developed as a partnership between ASCIA and A&AA. The Kotter's Change Management Model provided the basis for the steps undertaken to develop and implement the National Allergy Strategy. Two Allergy Summits, one for development and the other for implementation, were held. Several events were held to advocate for federal government funding. Five individual funding grants were achieved to implement National Allergy Strategy projects addressing the most urgent issues. CONCLUSION: The development of the National Allergy Strategy, a partnership between ASCIA and A&AA, was important in enabling successful advocacy for funding and implementation of important Australia-wide projects. The partnership has also helped facilitate engagement with key stakeholders to help advocate for funding and provide guidance and expertise in project implementation and resource development. The National Allergy Strategy has been successful in attracting funding to implement projects and develop resources urgently needed. The National Allergy Strategy has also provided a framework and a collaborative approach, for advocacy for further funding and future work to be undertaken. World Allergy Organization 2022-10-13 /pmc/articles/PMC9574709/ /pubmed/36267355 http://dx.doi.org/10.1016/j.waojou.2022.100706 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Full-Length Article Vale, Sandra L. Said, Maria Smith, Jill Joshi, Preeti Loh, Richard KS. Welcome back Kotter–Developing a National Allergy strategy for Australia |
title | Welcome back Kotter–Developing a National Allergy strategy for Australia |
title_full | Welcome back Kotter–Developing a National Allergy strategy for Australia |
title_fullStr | Welcome back Kotter–Developing a National Allergy strategy for Australia |
title_full_unstemmed | Welcome back Kotter–Developing a National Allergy strategy for Australia |
title_short | Welcome back Kotter–Developing a National Allergy strategy for Australia |
title_sort | welcome back kotter–developing a national allergy strategy for australia |
topic | Full-Length Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574709/ https://www.ncbi.nlm.nih.gov/pubmed/36267355 http://dx.doi.org/10.1016/j.waojou.2022.100706 |
work_keys_str_mv | AT valesandral welcomebackkotterdevelopinganationalallergystrategyforaustralia AT saidmaria welcomebackkotterdevelopinganationalallergystrategyforaustralia AT smithjill welcomebackkotterdevelopinganationalallergystrategyforaustralia AT joshipreeti welcomebackkotterdevelopinganationalallergystrategyforaustralia AT lohrichardks welcomebackkotterdevelopinganationalallergystrategyforaustralia |